The Activin A Receptor Type 1C (ACVR1C), also known as ALK-7, belongs to the transforming growth factor-beta (TGF-β) superfamily of serine/threonine kinase receptors. ACVR1C plays a significant role in various biological processes, including cell proliferation, differentiation, and apoptosis by mediating signals from activin A, a cytokine involved in numerous physiological functions. Research has indicated that ACVR1C is implicated in metabolic regulation, immune responses, and embryonic development. Dysregulation or mutations in this gene have been linked to several diseases, such as polycystic ovary syndrome (PCOS) and cancer. Studies on ACVR1C have revealed its potential as a therapeutic target for these conditions due to its influence on intracellular signaling pathways like SMAD-dependent and -independent pathways. Understanding the molecular mechanisms underlying ACVR1C's function could provide new insights into disease pathogenesis and pave the way for innovative treatments.